Inventor · disambiguated record
Hongyu Zhao
Also filed as: ZHAO HONGYU · ZHAO HONGYU H
16 granted patents·17 pending applications·100 citations·filing 2003–2025
89Inventor score
Files withABBVIE DEUTSCHLAND12ABBOTT LAB4AKRITOPOULOU-ZANZE IRINI2CHILDRENS MEDICAL CENTER2ABBVIE INC1
Top patents by PatentIndex Score
33 records- 0192US7119205B2Thienopyridones as AMPK activators for the treatment of diabetes and obesityABBOTT LAB·Filed 2004·Granted Oct 10, 2006·47 cites·14 claims
- 0290US7169797B2Protein-tyrosine phosphatase inhibitors and uses thereofABBOTT LAB·Filed 2004·Granted Jan 30, 2007·33 cites·12 claims
- 0384US7888374B2Inhibitors of c-jun N-terminal kinasesABBOTT LAB·Filed 2006·Granted Feb 15, 2011·9 cites·23 claims
- 0479US9656955B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 23, 2017·2 cites·20 claims
- 0578US7115767B2Tetraline derivatives as ghrelin receptor modulatorsABBOTT LAB·Filed 2004·Granted Oct 3, 2006·9 cites·21 claims
- 0661US2025304614A1Nucleic acid nanoswitch construction methodsCHILDRENS MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 0759US9586945B2Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·21 claims
- 0859US9586942B2Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·20 claims
- 0959US2005171132A1Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonistsFiled 2004·Application pending·0 cites
- 1058US12252507B2Nucleic acid nanoswitch construction methodsCHILDRENS MEDICAL CENTER·Filed 2017·Granted Mar 18, 2025·0 cites·5 claims
- 1158US2005048547A1Classification of disease states using mass spectrometry dataFiled 2004·Application pending·0 cites
- 1258US2019290632A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1358US2019290645A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1455US2023019236A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 1554US2006287356A1Thienopyridones as AMPK activators for the treatment of diabetes and obesityIYENGAR RAJESH R·Filed 2006·Application pending·0 cites
- 1653US2018346484A1Modulators of 5-ht receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1752US2017172993A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1852US2017173009A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1950US2023145200A1Compositions and methods of treating cancerTILLEAD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2049US2005171131A1Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonistsFiled 2004·Application pending·0 cites
- 2147US9879033B2Modulators of 5-HT receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 30, 2018·0 cites·9 claims
- 2246US9650334B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 16, 2017·0 cites·20 claims
- 2345US11970533B2Bispecific antibodies targeting human claudin 18.2 and programmed death-ligand 1 (PD-L1)SPARX BIOSCIENCE LTD·Filed 2021·Granted Apr 30, 2024·0 cites·30 claims
- 2445US9187483B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Nov 17, 2015·0 cites·13 claims
- 2544US2021188897A1Neuroactive steroids and compositions and methods thereofSPARX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2643US9957274B2Indane inhibitors of EED and methods of their useABBVIE INC·Filed 2017·Granted May 1, 2018·0 cites·9 claims
- 2742US2006089398A1Isoxazole carboxamide derivatives as ghrelin receptor modulatorsLIU GANG·Filed 2004·Application pending·0 cites
- 2841US9550754B24,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 24, 2017·0 cites·20 claims
- 2941US9365512B2Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Jun 14, 2016·0 cites·20 claims
- 3040US2012157324A1Methylation biomarkers and methods of useLIZARDI PAUL M·Filed 2010·Application pending·0 cites
- 3140US2005070712A1Pyrimidine derivatives as ghrelin receptor modulatorsFiled 2003·Application pending·0 cites
- 3239US2004167188A1Protein-tyrosine phosphatase inhibitors and uses thereofFiled 2003·Application pending·0 cites
- 3333US8846951B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Sep 30, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Hongyu Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →